EIP
ABMD

Ellis Investment Partners’s Abiomed Inc ABMD Stock Holding History

Ellis Investment Partners’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10
Closed -$2K – 811
2022
Q3 		$2K Hold
10
– – ﹤0.01% 738
2022
Q2 		$2K Hold
10
– – ﹤0.01% 742
2022
Q1 		$3K Hold
10
– – ﹤0.01% 739
2021
Q4 		$3K Hold
10
– – ﹤0.01% 739
2021
Q3 		$3K Hold
10
– – ﹤0.01% 722
2021
Q2 		$3K Hold
10
– – ﹤0.01% 725
2021
Q1 		$3K Hold
10
– – ﹤0.01% 708
2020
Q4 		$3K Hold
10
– – ﹤0.01% 674
2020
Q3 		$2K Hold
10
– – ﹤0.01% 685
2020
Q2 		$2K Buy
+10
New +$2.01K ﹤0.01% 677

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Ellis Investment Partners's ABMD Position: Q4 2022 in Review

Ellis Investment Partners sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 10 shares — an estimated $2K sold.

Ellis Investment Partners first reported a position in ABMD in Q2 2020 and held it in 10 quarters. The position peaked at $3K in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Ellis Investment Partners reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Ellis Investment Partners sold 10 Abiomed Inc shares in Q4 2022, an estimated $2K.
  • Ellis Investment Partners first reported a position in Abiomed Inc in Q2 2020 and held it in 10 quarters.
  • Ellis Investment Partners's Abiomed Inc position peaked at $3K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Ellis Investment Partners's 13F filing for Q4 2022, filed 31 Jan 2023.